Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice.

Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice.

BACKGROUND: 3'-Deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) is a tracer used to assess cell proliferation in vivo. The aim of the study was to use (18)F-FLT positron emission tomography (PET) to study treatment responses to a new anti-cancer compound. To do so, we studied early anti-prolife...

Full description

Bibliographic Details
Main Authors:	Mette Munk Jensen, Kamille Dumong Erichsen, Fredrik Björkling, Jacob Madsen, Peter Buhl Jensen, Liselotte Højgaard, Maxwell Sehested, Andreas Kjær
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC2945761?pdf=render

Similar Items

[18F]FLT PET for non-invasive assessment of tumor sensitivity to chemotherapy: studies with experimental chemotherapy TP202377 in human cancer xenografts in mice.
by: Mette Munk Jensen, et al.
Published: (2012-01-01)

Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET.
by: Mette Munk Jensen, et al.
Published: (2013-01-01)

18F-FDG and 18F-FLT-PET imaging for monitoring everolimus effect on tumor-growth in neuroendocrine tumors: studies in human tumor xenografts in mice.
by: Camilla Bardram Johnbeck, et al.
Published: (2014-01-01)

Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
by: Tine N. Christensen, et al.
Published: (2021-02-01)

A Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model.
by: Yilong Fu, et al.
Published: (2016-01-01)

Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by <sup>18</sup>F-FDG-microPET or external caliper
by: Jørgensen Jesper, et al.
Published: (2008-10-01)

[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer.
by: Isabella Raccagni, et al.
Published: (2018-01-01)

Intratumoral 18F-FLT infusion in metabolic targeted radiotherapy
by: Thititip Tippayamontri, et al.
Published: (2019-04-01)

An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.
by: Martha Nowosielski, et al.
Published: (2014-01-01)

Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancer
by: Tzu-Pei Su, et al.
Published: (2021-08-01)

Use of Molecular Imaging Markers of Glycolysis, Hypoxia and Proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a Dog with Fibrosarcoma: The Importance of Individualized Treatment Planning and Monitoring
by: Kamilla Westarp Zornhagen, et al.
Published: (2015-09-01)

Limits of [18F]-FLT PET as a biomarker of proliferation in oncology.
by: Eliot T McKinley, et al.
Published: (2013-01-01)

Differences between [<sup>18</sup>F]FLT and [<sup>18</sup>F]FDG Uptake in PET/CT Imaging in CC Depend on Vaginal Bacteriology
by: Ewa Burchardt, et al.
Published: (2021-12-01)

Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined 18F-FDG and 18F-FLT PET/CT imaging
by: C. Sachpekidis, et al.
Published: (2018-04-01)

(18)F-FDG PET imaging of murine atherosclerosis: association with gene expression of key molecular markers.
by: Anne Mette Fisker Hag, et al.
Published: (2012-01-01)

Comparison of 18F-FES, 18F-FDG, and 18F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer.
by: SiMin He, et al.
Published: (2016-01-01)

Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
by: Alexandra Nikaki, et al.
Published: (2019-01-01)

Value of pretreatment 18F-FLT PET/CT and 18F-FDG PET/CT uptake heterogeneity for early prediction of treatment outcome in locally advanced nasopharyngeal carcinoma
by: MA Guang, OU Xiaomin, HU Chaosu, SONG Shaoli, YANG Zhongyi
Published: (2022-04-01)

The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts.
by: Mette K Nedergaard, et al.
Published: (2014-01-01)

Radiomic analysis will add differential diagnostic value of benign and malignant pulmonary nodules: a hybrid imaging study based on [18F]FDG and [18F]FLT PET/CT
by: Jing Ning, et al.
Published: (2023-11-01)

18F-FLT PET/MRI for bone marrow failure syndrome-initial experience
by: Tetsuya Tsujikawa, et al.
Published: (2019-02-01)

One-Step Synthesis of <i>N</i>-Succinimidyl-4-[<sup>18</sup>F]Fluorobenzoate ([<sup>18</sup>F]SFB)
by: Ida Nymann Petersen, et al.
Published: (2019-09-01)

A zero-dose synthetic baseline for the personalized analysis of [18F]FDG-PET: Application in Alzheimer’s disease
by: Christian Hinge, et al.
Published: (2022-11-01)

18F-FDG PET/CT Findings in Cytomegalovirus Colitis
by: Anna Sophie L. Kjaer, et al.
Published: (2018-12-01)

The expression of miRNA-216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer
by: Mingfei Zuo, et al.
Published: (2021-09-01)

Imaging of atherosclerosis with [64Cu]Cu-DOTA-TATE in a translational head-to-head comparison study with [18F]FDG, and Na[18F]F in rabbits
by: Constance E. Grandjean, et al.
Published: (2023-06-01)

Evaluating [<sup>18</sup>F]FDG and [<sup>18</sup>F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models
by: Paolo Rainone, et al.
Published: (2023-09-01)

18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
by: Perrin E. Romine, et al.
Published: (2021-08-01)

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT in Lung Cancer
by: Kalevi Kairemo, et al.
Published: (2020-01-01)

Correction: Christensen et al. Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. <i>Diagnostics</i> 2021, <i>11</i>, 279
by: Tine N. Christensen, et al.
Published: (2022-07-01)

Comparison of 18F-FDG, 18F-Fluoroacetate, and 18F-FEPPA for Imaging Liver Fibrosis in a Bile Duct-Ligated Rat Model
by: Chun-Yi Wu, et al.
Published: (2021-01-01)

Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models
by: Outi Keinänen, et al.
Published: (2017-12-01)

Perfusion CT and PET with 18F–FDG and 18F–FCh in the complex diagnosis of hepatocellular carcinoma
by: P. E. Tulin, et al.
Published: (2017-12-01)

The 18F-FDG PET scan in oncology
by: T Thientunyakit
Published: (2007-12-01)

Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study
by: Kalevi Kairemo, et al.
Published: (2020-02-01)

The Positron Emission Tomography Tracer 3'-Deoxy-3'-[18F]Fluorothymidine ([18F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice.
by: Stefan Wiehr, et al.
Published: (2016-01-01)

[18F]Tosyl fluoride as a versatile [18F]fluoride source for the preparation of 18F-labeled radiopharmaceuticals
by: Dong Zhou, et al.
Published: (2023-02-01)

[18F]MPPF and [18F]FDG μPET imaging in rats: impact of transport and restraint stress
by: Verena Buchecker, et al.
Published: (2020-09-01)

The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice.
by: Emma J Haagensen, et al.
Published: (2013-01-01)

Prediction of Aortic Stenosis Progression by 18F-FDG and 18F-NaF PET/CT in Different Aortic Valve Phenotypes
by: Patimat Murtazalieva, et al.
Published: (2022-05-01)